Experienced in Parathyroid Adenoma

Dr. John Parker

Endocrinology
Wilmington Health PLLC
6781 Parker Farm Dr Ste 200, 
Wilmington, NC 
Offers Telehealth

Experienced in Parathyroid Adenoma
Wilmington Health PLLC
6781 Parker Farm Dr Ste 200, 
Wilmington, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Parker is an Endocrinologist in Wilmington, North Carolina. Dr. Parker is rated as an Experienced provider by MediFind in the treatment of Parathyroid Adenoma. His top areas of expertise are Cushing's syndrome, Exogenous Cushing's syndrome, Type 1 Diabetes (T1D), and Cushing's syndrome due to Adrenal Tumor.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in NC
Hospital Affiliations
J Arthur Dosher Memorial Hospital
Novant Health New Hanover Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Trustmark
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Wilmington Health PLLC
6781 Parker Farm Dr Ste 200, Wilmington, NC 28405
Call: 910-763-6332

Additional Areas of Focus

Dr. Parker has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drugs: LY3437943, Dulaglutide
Study Phase: Phase 2
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Semaglutide
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
Enrollment Status: Completed
Publish Date: May 01, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

5 Total Publications

Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.
Journal: Diabetes care
Published: May 05, 2025
View All 5 Publications
Similar Doctors
Advanced in Parathyroid Adenoma
Dr. Ghobad Azizi
Endocrinology
Advanced in Parathyroid Adenoma
Dr. Ghobad Azizi
Endocrinology

Wilmington Endocrinology PA

1717 Shipyard Blvd Ste 220, 
Wilmington, NC 
 (3.1 miles away)
910-254-9464
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ghobad Azizi is an Endocrinologist in Wilmington, North Carolina. Dr. Azizi is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Adenoma. His top areas of expertise are Thyroid Nodule, Thyroid Cancer, Hypothyroidism, Papillary Thyroid Cancer, and Thyroidectomy.

Maya Peltsverger
Experienced in Parathyroid Adenoma
Dr. Maya Peltsverger
Endocrinology | Internal Medicine
Experienced in Parathyroid Adenoma
Dr. Maya Peltsverger
Endocrinology | Internal Medicine

Novant Health Internal Medicine Wilmington

1725 New Hanover Medical Park Dr, 
Wilmington, NC 
 (0.9 miles away)
910-662-9300
Experience:
21+ years
Languages Spoken:
English, Russian
See accepted insurances
Offers Telehealth

Maya Peltsverger is an Internal Medicine specialist and an Endocrinologist in Wilmington, North Carolina. Dr. Peltsverger has been practicing medicine for over 21 years and is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Adenoma. Her top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, IPEX Syndrome, and Endoscopy.

Demetrios Herodotou
Experienced in Parathyroid Adenoma
Dr. Demetrios Herodotou
Endocrinology
Experienced in Parathyroid Adenoma
Dr. Demetrios Herodotou
Endocrinology

Novant Health Medical Group, LLC

204 Smith Ave, 
Shallotte, NC 
 (30.0 miles away)
704-384-9672
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Demetrios Herodotou is an Endocrinologist in Shallotte, North Carolina. Dr. Herodotou is rated as an Advanced provider by MediFind in the treatment of Parathyroid Adenoma. His top areas of expertise are Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Hypothyroidism.

VIEW MORE PARATHYROID ADENOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Parker's expertise for a condition
ConditionClose
    • Distinguished
    • Cushing's syndrome
      Dr. Parker is
      Distinguished
      . Learn about Cushing's syndrome.
      See more Cushing's syndrome experts
    • Cushing's syndrome due to Adrenal Tumor
      Dr. Parker is
      Distinguished
      . Learn about Cushing's syndrome due to Adrenal Tumor.
      See more Cushing's syndrome due to Adrenal Tumor experts
    • Exogenous Cushing's syndrome
      Dr. Parker is
      Distinguished
      . Learn about Exogenous Cushing's syndrome.
      See more Exogenous Cushing's syndrome experts
    • Type 1 Diabetes (T1D)
      Dr. Parker is
      Distinguished
      . Learn about Type 1 Diabetes (T1D).
      See more Type 1 Diabetes (T1D) experts
    • Advanced
    • Anaplastic Thyroid Cancer
      Dr. Parker is
      Advanced
      . Learn about Anaplastic Thyroid Cancer.
      See more Anaplastic Thyroid Cancer experts
    • Craniopharyngioma
      Dr. Parker is
      Advanced
      . Learn about Craniopharyngioma.
      See more Craniopharyngioma experts
    • Eunuchoidism Familial Hypogonadotropic
      Dr. Parker is
      Advanced
      . Learn about Eunuchoidism Familial Hypogonadotropic.
      See more Eunuchoidism Familial Hypogonadotropic experts
    • Follicular Thyroid Cancer
      Dr. Parker is
      Advanced
      . Learn about Follicular Thyroid Cancer.
      See more Follicular Thyroid Cancer experts
    • Growth Hormone Deficiency (GHD)
      Dr. Parker is
      Advanced
      . Learn about Growth Hormone Deficiency (GHD).
      See more Growth Hormone Deficiency (GHD) experts
    • Hyperthyroidism
      Dr. Parker is
      Advanced
      . Learn about Hyperthyroidism.
      See more Hyperthyroidism experts
    View All 27 Advanced Conditions
    • Experienced
    • Adrenal Gland Adenoma
      Dr. Parker is
      Experienced
      . Learn about Adrenal Gland Adenoma.
      See more Adrenal Gland Adenoma experts
    • Ballinger-Wallace Syndrome
      Dr. Parker is
      Experienced
      . Learn about Ballinger-Wallace Syndrome.
      See more Ballinger-Wallace Syndrome experts
    • Breast Enlargement In Males
      Dr. Parker is
      Experienced
      . Learn about Breast Enlargement In Males.
      See more Breast Enlargement In Males experts
    • Deafness Hypogonadism Syndrome
      Dr. Parker is
      Experienced
      . Learn about Deafness Hypogonadism Syndrome.
      See more Deafness Hypogonadism Syndrome experts
    • Diabetic Nephropathy
      Dr. Parker is
      Experienced
      . Learn about Diabetic Nephropathy.
      See more Diabetic Nephropathy experts
    • Diabetic Retinopathy
      Dr. Parker is
      Experienced
      . Learn about Diabetic Retinopathy.
      See more Diabetic Retinopathy experts
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.